On October 23, 2019, Varian Medical Systems, Inc. announced that it has appointed Gary E. Bischoping, Jr., currently Senior Vice President, Finance and Chief Finance Officer, to a new role as President, Interventional Oncology Solutions. J. Michael Bruff, currently Senior Vice President, Finance and Investor Relations, will succeed Mr. Bischoping as Senior Vice President, Finance and Chief Finance Officer. Both executives will report directly to Dow Wilson, the Company's President and Chief Executive Officer, and both changes will become effective on December 1, 2019.

Since joining the Company, Mr. Bruff served as Vice President of Investor Relations between August 2017 and February 2018 and has since served as Senior Vice President, Finance and Investor Relations. Prior to joining the Company, Mr. Bruff worked for Dell Technologies for 19 years in both domestic and international roles, most recently as Senior Vice President of North America Sales Strategy & Planning. Previously, he served as Senior Vice President and CFO of Dell's Asia Pacific and Japan Commercial Business and Vice President of the Greater China Commercial Business.

He also held executive and leadership roles in financial planning & analysis, internal audit and Enterprise Solutions Group finance.